Table 2.
Group | n | Days –14-–1 Normal |
Days 1-14 | Days 15-28 | Ratio of irregular cycle (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Normal | Prolonged | Stagnate | No cycle | Normal | Prolonged | Stagnate | No cycle | |||||
Blank | 20 | 20a | 19 | 0 | 1 | 0 | 18 | 1 | 1 | 0 | 10 | |
Model | 20 | 20 | 1 | 6 | 3 | 10 | 5 | 7 | 5 | 3 | 75 | |
BCD | 20 | 20 | 2 | 8 | 1 | 9 | 17 | 2 | 0 | 1 | 15b | |
EV | 20 | 20 | 1 | 5 | 6 | 8 | 17 | 1 | 1 | 1 | 15 |
Notes: blank group: equal amount of normal saline, 14 d; model group: equal amount of normal saline, 14 d; BCD group: Bushen Culuan decoction, 18.35 g·kg-1·d-1, 14 d; EV group: estradiol valerate intervening group, 0.15 mg·kg-1·d-1, 14 d. aP < 0.05, compared with the other 3 groups; bP < 0.05, compared with model group.